Sionna Stock 144% This Year: Is the Biotech a Buy Now?
Sionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
Understand what to expect from financial planning and accounting services. Make informed decisions for your financial future.
23,462 articlesSionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
Evernorth has filed Form S-4 as it advances a merger with Armada Acquisition Corp. II to take a Nasdaq-listed XRP tre...
Planned Parenthood of Illinois agreed to a $500,000 settlement with the EEOC after an investigation found DEI practic...
Rental-focused development dominated Q4 2025, with 91,000 rental starts among 96,000 total multifamily starts, a jump...
Bitcoin vaulted past $70,000 in minutes, sending a broad risk-on rally across assets. Analysts warn the move produced...
A majority of Americans fear AI-driven job losses will push the cost and effort of buying a home out of reach, accord...
A federal judge pressed the government over its bid to block Anthropic’s AI from top-secret systems. The hearing unde...
Morgan Stanley reports record revenue for 2025 and a solid Q4, but shares fall as liquidity constraints in private ma...
Mortgage rates jump to the mid-6% range as geopolitical risk rises, pushing borrowing costs closer than 7% and compli...
This week brought a sharp decline in lenz therapeutics stock plummeted as concerns about revenue growth and financing...
ZachXBT has renewed scrutiny of Tokenlon, a smaller decentralized exchange, alleging illicit funds flow. Tokenlon reb...
In early 2026, Tutor Perini faced a mix of growth opportunities and project-level headwinds. This article breaks down...